Related references
Note: Only part of the references are listed.Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R. Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Joon Hyeok Lee et al.
GASTROENTEROLOGY (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The yin and yang of evasion and immune activation in HCC
Oxana V. Makarova-Rusher et al.
JOURNAL OF HEPATOLOGY (2015)
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
Maria Neve Polimeno et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Sixian Liang et al.
ONCOTARGET (2015)
Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients
Naoko Sanuki et al.
ACTA ONCOLOGICA (2014)
Antitumor Effects in Hepatocarcinoma of lsoform-Selective Inhibition of HDAC2
Yun-Han Lee et al.
CANCER RESEARCH (2014)
CXCR4 as biomarker for radioresistant cancer stem cells
Franziska Trautmann et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Local Control Following Stereotactic Body Radiotherapy for Liver Tumors: A Preliminary Report of the AAPM Working Group for SBRT
N. Ohri et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
Wenyin Shi et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi-Sen Ding et al.
NATURE (2014)
Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
Yuya Yoshimoto et al.
PLOS ONE (2014)
Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity
Max Seidensticker et al.
PLOS ONE (2014)
An Autologous In Situ Tumor Vaccination Approach for Hepatocellular Carcinoma. 2. Tumor-Specific Immunity and Cure after Radio-Inducible Suicide Gene Therapy and Systemic CD40-Ligand and Flt3-Ligand Gene Therapy in an Orthotopic Tumor Model
Yujo Kawashita et al.
RADIATION RESEARCH (2014)
An Autologous In Situ Tumor Vaccination Approach for Hepatocellular Carcinoma. 1. Flt3 Ligand Gene Transfer Increases Antitumor Effects of a Radio-Inducible Suicide Gene Therapy in an Ectopic Tumor Model
Yujo Kawashita et al.
RADIATION RESEARCH (2014)
Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma
Shaelyn Culleton et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo
Wen Yu et al.
CANCER LETTERS (2013)
Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials
Zaiming Lu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
Jing Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis
Jia-yan Ni et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Phase II Trial of Palliative Radiotherapy for Hepatocellular Carcinoma and Liver Metastases
Hany Soliman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
Alexis Bujold et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma
Yohji Honda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma
Chiao-Ling Tsai et al.
ONCOLOGY (2013)
Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Sascha Venturelli et al.
PLOS ONE (2013)
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
Won Il Jang et al.
RADIATION ONCOLOGY (2013)
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
Shuichiro Shiina et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma
Tracy R. Price et al.
CANCER (2012)
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
Jin-Kyu Kang et al.
CANCER (2012)
Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
Inge Verbrugge et al.
CANCER RESEARCH (2012)
PHASE II STUDY OF CONCOMITANT THALIDOMIDE DURING RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
Hui-Ju Ch'ang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Radiosensitizing Effect of a Phenylbutyrate-Derived Histone Deacetylase Inhibitor in Hepatocellular Carcinoma
Yen-Shen Lu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma
Wen-Yen Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Utilization and Outcomes of Palliative Therapy for Hepatocellular Carcinoma A Population-based Study in the United States
Jessica A. Davila et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response
Marcelo E. Facciuto et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011
Peipei Song et al.
LIVER INTERNATIONAL (2012)
Distinct contribution of stem and progenitor cells to epidermal maintenance
Guilhem Mascre et al.
NATURE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
Sylvain Dewas et al.
RADIATION ONCOLOGY (2012)
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
Heon Joo Park et al.
RADIATION RESEARCH (2012)
Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models
Ju Hyun Shim et al.
RADIOLOGY (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2: Tumor and Immunological Responses
Steven K. Seung et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Junfang Ji et al.
SEMINARS IN ONCOLOGY (2012)
Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
Catherine Frenette et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours
Jorgen B. B. Petersen et al.
ACTA ONCOLOGICA (2011)
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria
A. N. Gordon-Weeks et al.
BRITISH JOURNAL OF SURGERY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
18F-fluorodeoxyglucose Uptake on Positron Emission Tomography as a Prognostic Predictor in Locally Advanced Hepatocellular Carcinoma
Beom Kyung Kim et al.
CANCER (2011)
GASTRODUODENAL COMPLICATIONS AFTER CONCURRENT CHEMORADIATION THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: ENDOSCOPIC FINDINGS AND RISK FACTORS
Young Eun Chon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
STEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY HEPATOCELLULAR CARCINOMA
David L. Andolino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Long-Term Outcome of Percutaneous Ablation in Very Early-Stage Hepatocellular Carcinoma
Ming Kuang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2011)
Hepatic Radiation Toxicity: Avoidance and Amelioration
Chandan Guha et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
Jung Hyun Kwon et al.
BMC CANCER (2010)
CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function
N. Sanuki-Fujimoto et al.
BRITISH JOURNAL OF RADIOLOGY (2010)
SORAFENIB AND RADIATION: A PROMISING COMBINATION IN COLORECTAL CANCER
Andrew W. Suen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
ANGIOGENIC BLOCKADE AND RADIOTHERAPY IN HEPATOCELLULAR CARCINOMA
Kwan-Hwa Chi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
Anne Hansen Ree et al.
LANCET ONCOLOGY (2010)
Radiofrequency Ablation for Hepatocellular Carcinoma: Updated Review in 2010
Masatoshi Kudo
ONCOLOGY (2010)
Accelerated Treatment Using Intensity-Modulated Radiation Therapy Plus Concurrent Capecitabine for Unresectable Hepatocellular Carcinoma
Alyson McIntosh et al.
CANCER (2009)
Evaluation of Tumor Response After Locoregional Therapies in Hepatocellular Carcinoma Are Response Evaluation Criteria in Solid Tumors Reliable?
Alejandro Forner et al.
CANCER (2009)
Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
Chen-Hsi Hsieh et al.
CLINICAL DRUG INVESTIGATION (2009)
Experimental mouse models for hepatocellular carcinoma research
Femke Heindryckx et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
A SYSTEMATIC ASSESSMENT OF RADIATION DOSE ENHANCEMENT BY 5-AZA-2′-DEOXYCYTIDINE AND HISTONE DEACETYLASE INHIBITORS IN HEAD-AND-NECK SQUAMOUS CELL CARCINOMA
Harlinde De Schutter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
EXTRAPOLATION OF NORMAL TISSUE COMPLICATION PROBABILITY FOR DIFFERENT FRACTIONATIONS IN LIVER IRRADIATION
An Tai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Mao-Bin Meng et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population
Roderich E. Schwarz et al.
AMERICAN JOURNAL OF SURGERY (2008)
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
Kwang-Hyub Han et al.
CANCER (2008)
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Regina V. Tse et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis
Miroslaw Kornek et al.
LIVER INTERNATIONAL (2008)
PROTON RADIOTHERAPY FOR LIVER TUMORS: DOSIMETRIC ADVANTAGES OVER PHOTON PLANS
Xiaochun Wang et al.
MEDICAL DOSIMETRY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma
Yeon Seok Seo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Bone marrow stem cells and liver disease
Y. N. Kallis et al.
GUT (2007)
Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - Mature results of the French phase II RTF-1 trial
Francoise Mornex et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Individualized image guided iso-NTCP based liver cancer SBRT
Laura A. Dawson et al.
ACTA ONCOLOGICA (2006)
Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance
Shi-Xiong Liang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Radiation therapy for hepatocellular carcinoma - From palliation to cure
MA Hawkins et al.
CANCER (2006)
Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma
BO Choi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study
HB El-Serag et al.
JOURNAL OF HEPATOLOGY (2006)
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies
E Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease
JCH Cheng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
A Munshi et al.
CLINICAL CANCER RESEARCH (2005)
Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients
T Chiba et al.
CLINICAL CANCER RESEARCH (2005)
Percutaneous radiofrequency ablation for hepatocellular carcinoma - An analysis of 1000 cases
R Tateishi et al.
CANCER (2005)
Local radiotherapy for patients with unresectable hepatocellular carcinoma
W Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients
JA Marrero et al.
HEPATOLOGY (2003)
Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients
J Seong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinical auto-analyzer
Y Yamagata et al.
CLINICA CHIMICA ACTA (2003)
Analysis of radiation-induced liver disease using the Lyman NTCP model
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
S Arii et al.
HEPATOLOGY (2000)
Share Paper
